Mechanisms underlying the varied mammary carcinogenicity of the environmental pollutant 6-nitrochrysene and its metabolites (-)-[R,R]- and (+)-[S,S]-1,2-dihydroxy-1,2-dihydro-6-nitrochrysene in the rat.

The mechanisms that can account for the remarkable mammary carcinogenicity of the environmental pollutant 6-nitrochrysene (6-NC) in the rat remain elusive. In our previous studies, we identified several 6-NC-derived DNA adducts in the rat mammary gland; one major adduct was derived from (±)-trans-1,2-dihydroxy-1,2-dihydro-6-nitrochrysene (1,2-DHD-6-NC). In the present study, we resolved the racemic (±)-1,2-DHD-6-NC into (-)-[R,R]- and (+)-[S,S]-1,2-DHD-6-NC and compared their in vivo mutagenicity and carcinogenicity in the mammary glands of female transgenic (BigBlue F344 × Sprague-Dawley)F1 rats harboring lacI/cII and Sprague-Dawley rats, respectively. Both [R,R]- and [S,S]-isomers exerted similar mutagenicity and carcinogenicity but were less potent than 6-NC. Additional in vivo and in vitro studies were then performed to explore possible mechanisms that can explain the higher potency of 6-NC than 1,2-DHD-6-NC. Using ELISA, we found that neither 6-NC nor 1,2-DHD-6-NC increased the levels of several inflammatory cytokines in plasma obtained from rats 24 h after treatment. In MCF-7 cells, as determined by immunoblotting, the effects of 6-NC and 1,2-DHD-6-NC on protein expression (p53, Akt, p38, JNK, c-myc, bcl-2, PCNA, and ERβ) were comparable; however, the expressions of AhR and ERα proteins were decreased by 6-NC but not 1,2-DHD-6-NC. The expression of both receptors was decreased in mammary tissues of rats treated with 6-NC. Our findings suggest that the differential effects of 6-NC and 1,2-DHD-6-NC on AhR and ERα could potentially account for the higher carcinogenicity of 6-NC in the rat mammary gland.

[1]  Kurt Straif,et al.  Carcinogenicity of diesel-engine and gasoline-engine exhausts and some nitroarenes. , 2012, The Lancet. Oncology.

[2]  V. Tam,et al.  A novel prenylflavone restricts breast cancer cell growth through AhR-mediated destabilization of ERα protein. , 2012, Carcinogenesis.

[3]  V. Arlt,et al.  Aryl hydrocarbon receptor activation during pregnancy, and in adult nulliparous mice, delays the subsequent development of DMBA‐induced mammary tumors , 2011, International journal of cancer.

[4]  Wei Xu,et al.  Endocrine disrupting chemicals targeting estrogen receptor signaling: identification and mechanisms of action. , 2011, Chemical research in toxicology.

[5]  L. Leung,et al.  2,3,7,8-Tetrachlorodibenzo-para-dioxin increases aromatase (CYP19) mRNA stability in MCF-7 cells , 2010, Molecular and Cellular Endocrinology.

[6]  I. Pongratz,et al.  AhR and ARNT modulate ER signaling. , 2010, Toxicology.

[7]  M. Lag,et al.  Differential effects of nitro-PAHs and amino-PAHs on cytokine and chemokine responses in human bronchial epithelial BEAS-2B cells. , 2010, Toxicology and applied pharmacology.

[8]  S. Amin,et al.  Stereoselective metabolism of the environmental mammary carcinogen 6-nitrochrysene to trans-1,2-dihydroxy-1,2-dihydro-6-nitrochrysene by aroclor 1254-treated rat liver microsomes and their comparative mutation profiles in a laci mammary epithelial cell line. , 2009, Chemical research in toxicology.

[9]  M. Lag,et al.  Cytokine and chemokine expression patterns in lung epithelial cells exposed to components characteristic of particulate air pollution. , 2009, Toxicology.

[10]  R. Norman,et al.  Comparative mutational profiles of the environmental mammary carcinogen, 6-nitrochrysene and its metabolites in a lacI mammary epithelial cell line. , 2007, Carcinogenesis.

[11]  S. Amin,et al.  Effects of the environmental mammary carcinogen 6-nitrochrysene on p53 and p21(Cip1) protein expression and cell cycle regulation in MCF-7 and MCF-10A cells. , 2007, Chemico-biological interactions.

[12]  D. Lagadic-Gossmann,et al.  Effects of nitrated-polycyclic aromatic hydrocarbons and diesel exhaust particle extracts on cell signalling related to apoptosis: possible implications for their mutagenic and carcinogenic effects. , 2007, Toxicology.

[13]  C. Dinarello,et al.  The paradox of pro-inflammatory cytokines in cancer , 2006, Cancer and Metastasis Reviews.

[14]  T. Zacharewski,et al.  Dioxin Induces an Estrogen-Like, Estrogen Receptor-Dependent Gene Expression Response in the Murine Uterus , 2006, Molecular Pharmacology.

[15]  A. Luch.  The Carcinogenic Effects of Polycyclic Aromatic Hydrocarbons , 2005 .

[16]  S. Amin,et al.  Tumorigenicity of Polycyclic Aromatic Hydrocarbons: "On the Possible Contribution of PAHs and their Nitro-Derivatives to the Development of Human Breast Cancer" , 2005 .

[17]  S. Amin,et al.  Mammary carcinogenesis and molecular analysis of in vivo cII gene mutations in the mammary tissue of female transgenic rats treated with the environmental pollutant 6-nitrochrysene. , 2003, Carcinogenesis.

[18]  Stephen Safe,et al.  The Aryl Hydrocarbon Receptor Mediates Degradation of Estrogen Receptor α through Activation of Proteasomes , 2003, Molecular and Cellular Biology.

[19]  Q. Ma.  Induction and superinduction of 2,3,7,8-tetrachlorodibenzo-rho-dioxin-inducible poly(ADP-ribose) polymerase: role of the aryl hydrocarbon receptor/aryl hydrocarbon receptor nuclear translocator transcription activation domains and a labile transcription repressor. , 2002, Archives of biochemistry and biophysics.

[20]  S. Amin,et al.  Metabolism and DNA binding of the environmental pollutant 6‐nitrochrysene in primary culture of human breast cells and in cultured MCF‐10A, MCF‐7 and MDA‐MB‐435s cell lines , 2002, International journal of cancer.

[21]  Brian Pittman,et al.  Comparative tumorigenicity of the environmental pollutant 6-nitrochrysene and its metabolites in the rat mammary gland. , 2002, Chemical research in toxicology.

[22]  S. Safe,et al.  Mechanism of action and development of selective aryl hydrocarbon receptor modulators for treatment of hormone-dependent cancers (Review). , 2002, International journal of oncology.

[23]  K. Hayakawa,et al.  Induction of CYP1A1, CYP1A2, and CYP1B1 mRNAs by nitropolycyclic aromatic hydrocarbons in various human tissue-derived cells: chemical-, cytochrome P450 isoform-, and cell-specific differences , 2002, Archives of Toxicology.

[24]  A. Manni,et al.  Immunohistochemical detection of ornithine-decarboxylase in primary and metastatic human breast cancer specimens , 2001, Breast Cancer Research and Treatment.

[25]  D. Jerina,et al.  Tumorigenicity of four optically active bay-region 3,4-diol 1, 2-epoxides and other derivatives of the nitrogen heterocycle dibenz[c,h]acridine on mouse skin and in newborn mice. , 2000, Carcinogenesis.

[26]  S. Amin,et al.  Synthesis of anti-1,2-dihydroxy-3,4-epoxy-1,2,3, 4-tetrahydro-6-nitrochrysene and its reaction with 2'-deoxyguanosine- 5'-monophosphate, 2'-deoxyadenosine-5'-monophosphate, and calf thymus DNA in vitro. , 2000, Chemical Research in Toxicology.

[27]  K. Bland,et al.  Estrogen-induced activation of Erk-1 and Erk-2 requires the G protein-coupled receptor homolog, GPR30, and occurs via trans-activation of the epidermal growth factor receptor through release of HB-EGF. , 2000, Molecular endocrinology.

[28]  R. Pollenz,et al.  Aryl Hydrocarbon Receptor Imported into the Nucleus following Ligand Binding Is Rapidly Degraded via the Cytosplasmic Proteasome following Nuclear Export* , 1999, The Journal of Biological Chemistry.

[29]  Cody L. Wilson,et al.  Mechanisms of Ligand-Induced Aryl Hydrocarbon Receptor-Mediated Biochemical and Toxic Responses , 1998, Toxicologic pathology.

[30]  J. French,et al.  Analysis of genetic instability during mammary tumor progression using a novel selection-based assay for in vivo mutations in a bacteriophage lambda transgene target. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[31]  P. Bontempo,et al.  Tyrosine kinase/p21ras/MAP‐kinase pathway activation by estradiol‐receptor complex in MCF‐7 cells. , 1996, The EMBO journal.

[32]  M. Manjanatha,et al.  Relationships of DNA adduct formation, K-ras activating mutations and tumorigenic activities of 6-nitrochrysene and its metabolites in the lungs of CD-1 mice. , 1994, Carcinogenesis.

[33]  S. Hecht,et al.  Induction of mammary cancer by 6-nitrochrysene in female CD rats. , 1993, Cancer research.

[34]  P. Fu,et al.  Carcinogen-DNA adduct formation in the lungs and livers of preweanling CD-1 male mice following administration of [3H]-6-nitrochrysene, [3H]-6-aminochrysene, and [3H]-1,6-dinitropyrene. , 1987, Cancer research.

[35]  A. Conney,et al.  Induction of microsomal enzymes by foreign chemicals and carcinogenesis by polycyclic aromatic hydrocarbons: G. H. A. Clowes Memorial Lecture. , 1982, Cancer research.

[36]  A. Frank.  Pathology of tumors in laboratory animals: Vol. II: Tumors of the Mouse. IARC Scientific Publication, WHO, Paris, 1980 , 1980 .

[37]  H. Waldron.  Environmental Health Criteria , 1980 .

[38]  L. Coussens,et al.  Soluble mediators of inflammation during tumor development. , 2005, Advances in cancer research.

[39]  S. Nesnow,et al.  Identification of 5-(deoxyguanosin-N2-yl)- 1,2-dihydroxy-1,2-dihydro-6-aminochrysene as the major DNA lesion in the mammary gland of rats treated with the environmental pollutant 6-nitrochrysene. , 2004, Chemical research in toxicology.

[40]  D. Jerina,et al.  Reactivity and tumorigenicity of bay-region diol epoxides derived from polycyclic aromatic hydrocarbons. , 1986, Advances in experimental medicine and biology.

[41]  D. Jerina,et al.  Tumorigenicity of enantiomers of chrysene 1,2-dihydrodiol and of the diastereomeric bay-region chrysene 1,2-diol-3,4-epoxides on mouse skin and in newborn mice. , 1983, Cancer research.